HAVCR2 and acute myeloid leukemia: (62) showed that Vδ2 T cell production of TNF-α and IFN-γ was increased by Tim-3 inhibition in combination with PD-1 inhibition but was insufficiently affected by PD-1 inhibition alone in AML patients.